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To better understand the mechanisms by which neurotropic viruses invade peripheral nerve pathways and produce CNS
disease, we defined the type 3 (T3) reovirus genes that are determinants of the capacity of reovirus T3 strain Dearing (T3D)
and T3 clone 9 (C9) to infect the spinal cord and kill mice after hindlimb injection. T3D and C9 viruses are both highly virulent
(LD50  10
1 PFU) after intracranial injection of neonatal mice. However, C9 is significantly more lethal than T3D after either
intramuscular injection (LD50  10
1 vs LD50 10
4 PFU) or peroral injection (LD50 10
3.4 vs LD50  10
8.3 PFU). Using reassortant
viruses containing different combinations of genes derived from T3D and C9, we found that the S1 gene, encoding the cell
attachment protein sigma 1 and the nonstructural protein sigma 1s, and the L3 gene, encoding the core shell protein lambda
1 were the primary determinants of lethality after intramuscular injection. The L3 gene and the L2 gene encoding spike
protein, lambda 2, determined differences in spinal cord titer after intramuscular injection. A C9  T3D mono-reassortant
containing all T3D genes except for the C9-derived L3 was lethal after peroral injection. These studies indicate that the S1,ess anINTRODUCTION
The central nervous system (CNS) is partially pro-
tected from systemic infections by the blood–brain bar-
rier. Neurotropic viruses employ several strategies to
penetrate this defense and produce neurological dis-
ease (Mims, 1987). Bloodborne viruses may invade neu-
ral tissue after infecting vessels in the brain or spinal
cord or may spread to neural sites through the cerebro-
spinal fluid (CSF) by crossing the blood– (CSF) junction
in the meninges or choroid plexus. Neurally spreading
viruses can evade the blood–brain barrier by utilizing
peripheral nerve fibers as direct pathways into the CNS.
Rabies virus, poliovirus, herpes simplex virus, and reo-
virus travel via the fast axonal transport system in motor,
sensory, or autonomic fibers to spread through the ner-
vous system from extraneural sites of infection
(Nathanson and Tyler, 1997).
Reovirus infection of neonatal mice has provided an
important animal model for studying the pathogenesis of
virus-induced CNS disease. Different reovirus serotypes
have been identified based on neutralization and hem-
1 Present address: College of Physicians and Surgeons 11-519, Co-
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2 To whom correspondence and reprint requests should be ad-213agglutination-inhibition assays (Nibert and Schiff, 2001),
and viruses belonging to these serotypes differ in their
pattern of CNS infection. Serotype 1 reoviruses primarily
spread to the CNS by hematogenous routes, infect
ependymal cells, and produce a generally nonlethal
ependymitis (Tyler and Fields, 1996). However, after in-
tramuscular or peroral injection serotype 3 viruses utilize
peripheral nerve pathways to invade the CNS, infect
neurons, and produce lethal encephalitis (Tyler et al.,
1986; Morrison et al., 1991). Because reoviruses contain
10 segments of dsRNA, most encoding a single major
protein, reassortant viruses may be generated from par-
ents exhibiting unique patterns of disease (Nibert and
Schift, 2001). Analysis of the pathogenesis of reassortant
viruses after intracranial injection (IC) has shown that the
major product of the S1 gene, virus cell attachment
protein, sigma 1, determines tropism for neurons or
ependymal cells by serotype 3 and serotype 1 viruses,
respectively (Weiner et al., 1977). Among serotype 3
strains, the product of theM2 gene, a major outer capsid
structural protein, mu 1, influences differences in the
capacity of these viruses to grow in the brain (Hrdy et al.,
1982). Thus, at least two reovirus genes play distinct
roles in determining neurovirulence after IC injection.
After hindlimb injection, type 3 reovirus travels to theL2, and L3 genes all play a potential role in neuroinvasiven
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Viruses are carried to the spinal cord by fast axonal
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transport (Tyler et al., 1986) and within 14 h viral antigens
are detected in spinal cord motor neurons ipsilateral to
the injection site (Flamand et al., 1991). To identify genes
that influence type 3 reovirus neuroinvasiveness, we first
identified two neurotropic type 3 viruses that differ in
lethality when injected into the hindlimb but not after
injection into the brain. We reasoned that such viruses
might differ at early steps in pathogenesis (primary rep-
lication and/or spread to the nervous system), yet be
similar at later steps (tropism and growth in the brain). By
analysis of the pathogenesis of reassortant viruses gen-
erated from these viruses, we identified reovirus genes
important for type 3 reovirus invasion of the central
nervous system after peripheral injection.
RESULTS
Characterization of reassortant viruses
In 1-day old mice, we found that two type 3 reoviruses,
strain Dearing (T3D) and clone 9 (C9), had similar 50%
lethal doses (LD50) by the intracranial (IC) route of injec-
tion (LD50  5 plaque-forming units (PFU)/mouse). How-
ever, 1000 times more T3D than C9 virus was required for
an LD50 after intramuscular (IM) injection (LD50 for T3D
104 vs LD50 for C9  10
1). To determine the genetic basis
for this difference in neuroinvasiveness, we character-
ized a panel of T3D  C9 reassortant viruses generated
by coinfection of murine L929 cells (Table 1). Viral geno-
types were defined by analysis of the migration patterns
of the dsRNA gene segments in polyacrylamide gels. As
reported previously for intertypic (Type 1  Type 3) reo-
virus reassortants (Nibert et al., 1996), we found a non-
random distribution of certain genes in the intratypic
T3D  C9 reassortants. The M1 and M2 genes coseg-
regated in all reassortants and the T3D L2 gene was
present in all but two reassortants.
Genetic determinants of lethality after im injection
To identify the gene(s) associated with route-specific
lethality differences, we determined the LD50 of each
reassortant after hindlimb injection of 1-day old mice.
Three to five dilutions of each of the 32 viruses were
injected into groups of four to six mice (total 768 mice).
The resulting LD50s exhibited a range of values (lethal
viruses having the lowest LD50), with no clear gap be-
tween more and less lethal groups (Table 1). No reas-
sortant was more lethal than the parental C9; however,
several were less lethal than T3D. Statistical analysis
demonstrated a significant association between lethality
and the derivation of the S1 (MW test, P  0.002; t test,
P  0.001) and the L3 (MW test, P  0.016; t test, P 
0.016) genes and a possible but less significant associ-
ation between lethality and the S2 gene (MW test, P 
0.03; t test, P  0.4). To calculate the influence on
lethality of individual C9 genes in the context of all other
genes, we subjected the data to linear regression anal-
ysis with each gene an independent variable, except for
the cosegregating genes, M1 and M2, which were
treated as a single variable (Fig. 1). Two C9 genes were
associated with significant increases in virus lethality.
The presence of a C9-derived L3 gene was associated
with an approximate reduction in LD50 of 1.8 log (P 
0.001), while the presence of a C9-derived S1 gene
reduced LD50 by 1.6 log (P  0.001). Conversely, the
presence of a C9-derived M1/M2 gene pair tended to
make reassortants less lethal, increasing LD50 by about
1 log (P  0.03). The regression equation accounted for
67% of the variance seen in the data (R2  0.67, P 
0.001, where R2, the square of the multiple correlation,
represents the proportion of the variance in the depen-
TABLE 1
T3D  C9 Reassortants
Virus
strain
Origin of the gene segmenta
LD50
b Titerc
POd
%L1 L2 L3 M1 M2 M3 S1 S2 S3 S4
C9 9 9 9 9 9 9 9 9 9 9 0.5 5.5 0
56 9 3 9 9 9 9 9 9 3 9 1.4 1.2 0
42 9 3 9 3 3 9 9 3 3 3 1.5 2.3 100
1.84 9 3 9 3 3 9 9 9 9 9 1.7 3.9 40
Z10 9 3 9 9 9 9 9 9 9 9 1.7 1.6 60
2.11 3 3 9 3 3 3 3 3 3 3 1.7 2.2 20
1.46 3 3 9 3 3 3 9 3 3 3 1.9 4.8 0
1.217 3 3 9 3 3 3 9 3 3 9 2.1 3.5 0
1.211 9 3 3 3 3 3 9 3 3 9 2.2 0.0 0
1.4 3 9 3 3 3 9 9 3 3 9 2.3 4.4 75
1.5 3 3 9 3 3 3 9 3 9 9 2.3 3.7 40
1.118 3 3 9 3 3 3 3 3 9 9 2.6 1.4 40
65 3 3 9 9 9 9 9 3 9 9 2.6 3.9 75
1.77 3 3 3 3 3 3 9 3 3 9 2.8 2.2 60
3.8 3 3 3 3 3 3 9 9 3 9 3.0 0.0 0
1.54 9 3 9 3 3 9 3 3 3 9 3.1 4.9 100
1.9 3 3 9 3 3 9 9 3 9 9 3.2 0.8 20
48 3 3 9 3 3 9 3 3 3 9 3.3 2.7 100
62 3 3 3 3 3 9 9 3 9 9 3.4 2.0 100
1.33 3 3 9 3 3 3 3 3 9 3 3.8 1.8 100
T3D 3 3 3 3 3 3 3 3 3 3 4.0 1.9 100
45 3 3 3 3 3 3 3 3 3 9 4.2 1.2 75
1.39 9 3 3 9 9 3 9 3 3 3 4.5 1.0 100
57 3 3 9 9 9 9 3 3 9 9 4.7 1.6 100
1.219 3 9 3 3 3 9 3 3 3 9 5.0 3.6 100
4.19 9 3 9 3 3 9 9 9 9 3 5.0 0.0 100
1.109 3 3 3 9 9 3 9 3 3 9 5.0 0.0 100
82 3 3 9 9 9 3 3 3 3 9 5.1 2.3 100
1.6 3 3 9 9 9 3 3 3 9 9 6.0 0.7 100
1.71 3 3 3 9 9 9 3 3 3 9 6.0 0.0 100
26 9 3 3 3 3 9 3 3 9 9 6.0 1.3 100
32 9 3 3 9 9 3 3 3 3 9 6.0 0.0 100
a Parental origin of gene segment: 3, gene derived from T3D: 9, gene
derived from C9.
b Lethality expressed as median lethal dose (LD50) in log10 PFU/
mouse.
c Titer of virus in spinal cord on day 5 postinoculation (log10 PFU/ml).
d Percentage of injected animals surviving after peroral injection.
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dent variable accounted for by the independent vari-
ables). Taken together, these results suggested that the
difference in T3D and C9 lethality after skeletal muscle
injection was multigenic, i.e., the C9 L3 and S1 genes
increased virus lethality, while the C9 M1 and/or M2
gene(s) tended to decrease lethality.
Because the substitution of certain C9 genes in-
creased T3D lethality after IM injection, we analyzed
separately the subset of viruses carrying the T3D S1
gene (Table 2). All viruses more lethal than T3D con-
tained the C9 L3 gene, and the most lethal virus was
mono-reassortant 2.11, with an LD50 2.3 log lower than
that of T3D. Conversely, all reassortants containing the
C9 M1/M2 gene pair were less lethal than T3D. In those
reassortants with both the C9 L3 and the C9 M1/M2
genes, the M1/M2 decrease in lethality was dominant.
Thus while the association between lethality and the
derivation of the M1/M2 gene pair (MW test, P  0.015;
t test, P  0.012) was statistically significant in this set of
reassortants, the association between lethality and the
derivation of the L3 gene was not (MW test, 0.058; t test,
P  0.055). However, regression analysis, which identi-
fies the contribution of each variable while allowing for
the contribution of the other independent variables, sug-
gested that the C9 L3 gene was associated with in-
creased lethality (LD50 reduced by 1.5 log, P  0.02),
while the C9 M1/M2 decreased lethality (LD50 increased
by 1.8 log, P  0.01). The regression equation accounted
for 85% (P  0.03) of the variance in LD50. Thus, while
substitution of the C9 L3 gene increased T3D lethality,
the C9 M1/M2 pair had an opposite, and dominant,
effect.
Lethality after peroral injection
C9 reovirus is lethal after peroral (PO) injection while
T3D is not (Rubin and Fields, 1980; Morrison et al., 1991;
Tyler et al., 1989); however, the genetic basis of this
difference has not been identified. To determine whether
the reassortants shown to be more lethal after skeletal
FIG. 1. Contribution of individual C9 genes to virus lethality. Each bar represents the difference in LD50 contributed by a single gene in association
with all other genes after im injection of T3D  C9 reassortants in 1-day old mice. **P  0.0008; *P  0.001.
TABLE 2
Lethalitya of T3D  C9 Reassortants Carrying the T3D
S1 Gene Segment
Virus
strain
Origin of the gene segmentb
LD50L1 L2 L3 M1 M2 M3 S1 S2 S3 S4
C9 9 9 9 9 9 9 9 9 9 9 0.5
2.11 3 3 9 3 3 3 3 3 3 3 1.7
1.118 3 3 9 3 3 3 3 3 9 9 2.6
1.54 9 3 9 3 3 9 3 3 3 9 3.1
48 3 3 9 3 3 9 3 3 3 9 3.3
1.33 3 3 9 3 3 3 3 3 9 3 3.8
T3D 3 3 3 3 3 3 3 3 3 3 4.0
45 3 3 3 3 3 3 3 3 3 9 4.2
57 3 3 9 9 9 9 3 3 9 9 4.7
1.219 3 9 3 3 3 9 3 3 3 9 5.0
82 3 3 9 9 9 3 3 3 3 9 5.1
1.6 3 3 9 9 9 3 3 3 9 9 6.0
1.71 3 3 3 9 9 9 3 3 3 9 6.0
26 9 3 3 3 3 9 3 3 9 9 6.0
32 9 3 3 9 9 3 3 3 3 9 6.0
a Lethal dose 50 (LD50) in log10 PFU/mouse, after im injection of 1-day
old mice.
b Parental origin of gene segment: 3, gene derived from T3D: 9, gene
derived from C9.
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muscle injection were also more lethal after peroral
injection, we injected groups of four to five 1-day old
mice with each reassortant (135 mice) at a dose at which
C9 killed 100% of injected mice while T3D killed few
mice. Results were calculated as percentage survival
and compared with LD50 after IM injection (Table 1). As
was seen after IM injection, reassortants carrying the C9
S1 gene tended to be most virulent after PO injection.
However, two viruses carrying the T3D S1 gene killed
more than 50% of the mice: 2.11, the mono-reassortant
carrying the C9 L3 gene, and 1.118, carrying the C9 L3,
S3, and S4 genes. These also were the T3D reassortants
most virulent after IM injection. To quantify this result, PO
LD50s were calculated for these two reassortants, as well
as for T3D and C9 (Table 3). LD50s were 3.4, 6.3, and 6.4
log10 PFU per mouse for C9, 2.11, and 1.118, respectively.
However, the highest dose of T3D (8.3 log10 PFU) was
insufficient for an LD50. Thus, substitution of the C9 L3
gene alone was sufficient to confer lethality after peroral
injection to T3D, a virus normally avirulent by this route.
Spinal cord infection after IM injection
Ventral spinal cord neurons ipsilateral to the injection
site are the first site of virus replication in the CNS after
hindlimb injection (Tyler et al., 1986; Flamand et al., 1991).
To determine whether T3D and C9 differed in their ca-
pacity for spinal cord infection after IM injection, we
injected groups of 1-day old mice with 102 PFU of virus,
a dose expected to kill all C9- and a few T3D-infected
pups. Viral titer was measured in muscle, spinal cord,
and brain tissue collected on alternate days after injec-
tion (Figs. 2A and 2B). Both viruses replicated well in
muscle, suggesting that differences in the capacity of
these viruses to replicate in skeletal muscle were not
responsible for differences in neuroinvasiveness or le-
thality. In contrast, by 5 days postinjection there was a 4
log difference between T3D and C9 titers in spinal cord
and brain. This suggested that there was a difference in
either the capacity of these viruses to spread or the
capacity to replicate within the spinal cord. To distin-
guish between these possibilities, and because direct
spinal cord injection of virus was not feasible in newborn
mice, we injected 1-day-old mice in the hindlimb with a
100 times larger dose of each virus (104 PFU) than was
used in our initial experiments. This dose of virus pro-
duced measurable spinal cord titers by 24 h postinjec-
tion (Fig. 2C), suggesting that if there is a defect in
spread it is relative rather than absolute. At this dose,
T3D and C9 grew at a similar rate over the first 5 days
after injection. However, at each time point, the titer of
T3D was about 10-fold less than that of C9. These results
suggested either that T3D might be less efficient than C9
in the initiation of spinal cord infection, that is, while both
grew well once infection was established, higher doses
of T3D were required to produce comparable spinal cord
titers, or that less virus was produced per infected cell.
To identify the gene(s) responsible for differences in
TABLE 3
Comparison of Lethalitya after Intramuscular (IM) and Peroral (PO)
Injection of T3D  C9 Reassortants Carrying the T3D S1 Gene
Segment
Virus name
Origin of the gene segmentb
IM LD50 PO LD50L1 L2 L3 M1 M2 M3 S1 S2 S3 S4
C9 9 9 9 9 9 9 9 9 9 9 0.5 3.4
2.11 3 3 9 3 3 3 3 3 3 3 1.7 6.4
1.118 3 3 9 3 3 3 3 3 9 9 2.6 6.3
T3D 3 3 3 3 3 3 3 3 3 3 4.0 8.3
a Lethal dose 50 (LD50) in log10 PFU/mouse, after IM or PO injection
of 1-day old mice.
b Parental origin of gene segment: 3, gene derived from T3D: 9, gene
derived from C9.
FIG. 2. Virus growth after IM injection. (A, B) One-day old pups were injected with a low dose (102 PFU) T3D (A) or C9 (B) virus, and tissue collected
for titer at various times after injection. Each point represents the mean virus titer  standard error in muscle, spinal cord, and brain of three mice,
from one of two experiments. (C) One-day old mice were injected with a higher dose (104 PFU) of T3D or C9. Each point represents average spinal
cord titer  standard error (n  3).
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T3D and C9 spinal cord infection, we measured viral
titers in spinal cord tissue collected 5 days after hindlimb
injection of three to six 1-day-old mice with 102 PFU of
each reassortant (total 195 mice). This time point had
shown clear differences between T3D and C9 spinal
cord titers but lower standard deviations than Day 3 (Fig.
2). The panel of reassortants produced a range of titers
(Table 1). C9 produced the highest titer, while T3D fell
midway between C9 and reassortants producing no de-
tectable spinal cord titer at Day 5. Reassortants with the
highest titers tended to carry the C9 L3 gene. Statistical
analysis demonstrated a significant association between
spinal cord titer and the derivation of the L3 (MW test,
P  0.028, t test, P  0.033) and L2 (MW test, P  0.018,
t test, P  0.004) genes. Because few reassortants car-
ried the L2 gene, additional reassortants will be required
to confirm this result. However, the behavior of the C9
mono-reassortant carrying the T3D L2 gene (spinal cord
titer 3.9 logs lower than C9) supported a role for the L2
gene in spinal cord infection. Although the S1 gene was
implicated in lethality, it was not associated with differ-
ences in spinal cord infection. To determine the influence
of individual genes on Day 5 spinal cord titers, we sub-
jected the data to linear regression analysis (Fig. 3). The
C9 L2 gene increased spinal cord titer by 3.2 log (P 
0.001). The C9 L3 gene increased titer by 2.0 log (P 
0.001). The regression equation accounted for 59% of the
variation seen in the data (R2  0.59, P  0.007). Thus,
after IM injection, the L3 gene influenced spinal cord
infection, as it had virus lethality. The correlation be-
tween Day 5 spinal cord titer and virus lethality was
significant (Spearmann rank correlation, P  0.005; sim-
ple regression, P  0.001) but accounted for only 31% of
the variance. Thus, spread to the spinal cord after IM
injection, as measured by Day 5 virus titer, was a weak
predictor of reassortant lethality.
DISCUSSION
The neurotropic type 3 reoviruses use peripheral
nerve fibers to invade the CNS from extraneural sites of
infection (Tyler et al., 1986; Morrison et al., 1991). Field
isolates, T3D and C9, are highly virulent after intracranial
injection of neonatal mice; however, C9 is significantly
more lethal than T3D after intramuscular injection. To
better understand the mechanisms by which viruses
invade peripheral nerve pathways to produce CNS dis-
ease, we used reassortant viruses to identify virus genes
important for differences in type 3 reovirus neuroinvasion
following inoculation at different sites in the mouse.
Nonrandom segregation of T3D  C9 genes
This article is the first characterization and usage of
T3D  C9 intratypic reassortants to identify differences
in neuroinvasion between type 3 viruses with similar
tropism and neurovirulence. In the panel of reassortants
we found that certain genes cosegregated (M1 and M2)
or were underrepresented (C9 L2). In addition, none of
the T3D reassortants (carrying T3D S1) incorporated the
C9 S2 gene. Nonrandom distribution of reovirus gene
segments has been reported previously for intertypic
serotype 1, Lang (T1L)  serotype 3 (T3D) reovirus reas-
sortants (Nibert et al., 1996). As in our T3D  C9 reas-
sortants, the T3D L2 gene was found in most of the
intertypic reassortants, and the T3D L3 and T3D S4
genes were somewhat underrepresented. Interestingly,
FIG. 3. Regression analysis of the contribution of C9 genes to spinal cord titer. Each bar represents the difference in spinal cord titer contributed
a single gene in association with all other genes 5 days after IM injection of T3D  C9 reassortants in 1-day old mice. *P  0.001.
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in our panel, the two reassortants carrying the C9 L2
gene had the same genotype except for the S1 gene.
Thus, a specific interaction between lambda 2 and one
or more C9 proteins other than, or in addition to, sigma 1
may be necessary to produce a viable reassortant. An
increased frequency of homologous pairing of certain
parental alleles was reported for the T1L  T3D reas-
sortants, but not of M1 and M2, and, in no case did the
parental alleles invariably cosegregate. The mecha-
nisms responsible for the nonrandom nature of reovirus
reassortment are unknown. Evidence for structural
and/or functional interactions between reovirus proteins
has been demonstrated by extragenic suppression of
temperature-sensitive phenotypes (McPhillips and
Ramig, 1984) and by identification of serotype-associated
patterns of monoclonal antibody binding to outer capsid
reovirus proteins (Virgin et al., 1991).
Lethality after IM injection
Two genes, S1 and L3, were primarily associated with
lethality differences between T3D and C9 after hindlimb
injection. The S1 gene, encoding the viral cell attachment
protein, sigma 1, defines reovirus serotype and is respon-
sible for serotype-specific differences in disease pheno-
type after intracranial injection (Weiner et al., 1980). Type
1 reovirus infection produces a generally nonlethal
ependymitis, while type 3 infection produces a lethal
encephalitis (Tyler and Fields, 1996). Thus, an associa-
tion of S1 with differences in reassortant lethality is not
surprising. Previous associations of the S1 gene with
differences in neuroinvasion using intertypic T1L  T3D
reassortants (Tyler et al., 1986; Bodkin and Fields, 1989),
reassortants made using T3D and an immune selected
variant (Kaye et al., 1986), and variants selected in severe
combined immunodeficient (SCID) mice (Haller et al.,
1995), all correlated with differences in virulence after
intracranial injection. However, the difference between
T3D and C9 lethality after IM injection was not associ-
ated with a difference in lethality after IC inoculation.
After IC injection, the LD50 values for both T3D and C9
are less than 10 PFU/mouse. Thus, the present identifi-
cation of the S1 gene contribution to lethality after hind-
limb injection suggests additional roles of the sigma 1
protein that are specific to the routes of neuroinvasion
studied here.
The reovirus L3 gene was a determinant of reovirus
lethality for the IM, as well as the PO (see below), routes.
The L3 gene product, lambda 1, is the major structural
component of the inner shell of the viral capsid, which
organizes the packing of the genomic RNA. Lambda 1 is
believed to act as a helicase during transcription by the
lambda 3 protein (Reinisch et al., 2000; Bisaillon et al.,
1997; Noble and Nibert, 1997). Differences in the lambda
1 protein may affect the stability of the virus core, a
multienzyme protein shell which must remain intact dur-
ing virus uncoating and transcription of single-stranded
RNA and/or may affect enzymatic activities required for
viral transcription in different cell types. Strain-specific
differences in the ATPase activities associated with the
lambda 1 protein have been found in vitro, but T3D and
C9 have not been compared (Noble and Nibert, 1997).
Genes encoding core proteins, including L3, have been
shown to influence virus growth in cultured mouse heart
cells (Matoba et al., 1991). However, no in vivo phenotype
had been mapped to the L3 gene previously.
The M1 and/or M2 gene(s) also contributed to differ-
ences in T3D and C9 lethality and had the opposite effect
of S1 and L3. TheM1 gene encodes inner capsid protein,
mu 2, an NTPase with RNA-binding activity that forms
part of the virus transcription complex (Brentano et al.,
1998). Reassortant analysis has linked a group of genes,
including M1, with virus induction of myocarditis in new-
born mice (Sherry and Blum, 1994) and with the extent of
replication in cultured mouse heart cells and bovine
aortic endothelial cells (Matoba et al., 1993). The M2
gene encodes a major outer capsid protein, mu 1. The
M2 gene has been shown to influence neurovirulence
among Type 3 strains when injected into the brain of
newborn mice (Hrdy et al., 1982). Growth in the CNS and
virulence was decreased in virus T3H/Ta (now T3 clone
8), a phenotype that mapped to the M2 gene. Interest-
ingly, a close relationship between the type 3M1 andM2
genes has been suggested by the extragenic suppres-
sion ofM2 attenuation by theM1 gene and restoration of
T3, clone 8 virulence (Jayasuriya, 1991).
Lethality after PO injection
In addition to demonstrating a role for the lambda 1
protein in neuroinvasion after skeletal muscle injection,
we also found that the C9 L3 gene confers lethality to
T3D after peroral injection, the natural route of reovirus
infection. T3D avirulence has been attributed to the
sigma 1 protein, which is sensitive to cleavage by pro-
teases and is associated with reduced virus growth in
the intestine (Bodkin and Fields, 1989; Nibert et al., 1995).
However, in our reassortants, a single C9 gene, L3, was
sufficient to confer lethality after PO injection to a T3D
mono-reassortant carrying the protease-sensitive T3D
sigma 1 protein. Because the lambda 1 protein is located
in the inner capsid, this result is not likely the result of a
steric protection of the sigma 1 cleavage site, as has
been suggested for the lambda 2 spike protein (Bodkin
and Fields, 1989). However, the lambda 1, lambda 2,
lambda 3, and sigma 1 proteins together comprise the
structurally dynamic vertex of the viral capsid where cell
binding, viral transcription, and extrusion of mRNA are
localized. Thus a change in one protein in the complex
may affect the function of another. A contribution of
genes other than S1 to T3D lethality after PO injection
was also suggested in previous studies by Chappell et
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al. (1997). The sigma 1 protein of a T3D variant isolated
from SCID mice revealed a single amino acid change
associated with resistance to protease cleavage. Com-
pared to T3D, this virus showed increased growth in
intestine but decreased growth in the brain in SCID mice.
In neonatal mice, growth in intestine and the spread to
the brain after PO injection were increased, but growth in
the brain and virulence were decreased after IM injec-
tion.
Spinal cord infection after IM injection
At low doses, T3D appeared to infect the CNS more
slowly than C9 after hindlimb injection. However, when
tested at higher doses, the rate of virus growth in the
spinal cord was similar for both T3D and C9, but 10-fold
more infectious virus particles were required to produce
similar titers. Other studies suggest that T3D and C9 are
both rapidly transported to the neural soma, producing
antigen-positive neurons 14–15 h after hindlimb injection
(Flamand et al., 1991; Mann et al., 2002). Thus T3D and
C9 may differ in efficiency of invasion of neonatal nerve
terminals, or at an early step in replication in motor
neurons.
The difference in Day 5 spinal cord titer was associ-
ated with the L3, and possibly the L2, gene. Together, the
L3 and L2 genes have been associated previously with
differences in virus growth in cardiac cell cultures (Ma-
toba et al., 1991). Pentameric complexes of the L2 prod-
uct, lambda 2, form hollow spikes through which inter-
nally transcribed mRNA exits the viral particle (Nibert
and Schift, 2001). Because lambda 2 anchors sigma 1 in
the outer capsid and caps nascent mRNAs as they exit
the inner core (Reinisch et al., 2000), this protein may
influence the efficiency and/or stability of the capsid
during binding, uptake, and targeting to endosomes, as
well as the production of viral mRNA and its delivery to
the host cytoplasm. The L2 gene has been previously
associated genetically with differences in the efficiency
of reovirus horizontal spread between infected and un-
infected littermates (Keroack and Fields, 1986) and in
association with the S1 andM1 genes with differences in
reovirus growth in the intestine early in PO infection
(Bodkin and Fields, 1989). In association with the M1
gene, the L2 gene has been associated genetically with
induction of myocarditis (Sherry and Blum, 1994).
Lethality and spinal cord infection
The set of genes determining differences in viral titers
in Day 5 spinal cord after IM injection was somewhat
different from that determining lethality differences by the
same route. The L2 gene appeared to be the stronger
determinant of spinal cord infection, yet did not signifi-
cantly affect virus lethality. Conversely, the S1 gene was
the stronger determinant of lethality after IM injection, yet
had no significant effect on differences in spinal cord
titers. The M1/M2 gene pair also influenced lethality but
not spinal cord invasion. Only the L3 gene influenced
both lethality and spinal cord infection and was sufficient
to rescue T3D lethality after PO injection. However, after
im injection, the paired contribution of S1 and L3 to
lethality and of L2 and L3 to spread outweighed the
independent contribution of L3 to each, and in the subset
of T3D reassortants, the decrease in lethality associated
with the C9 M1/M2 genes negated the increase associ-
ated with L3. Functional interdependence among type 3
proteins is suggested by the nonrandom reassortment of
T3D and C9 genes (see above). In addition, the identifi-
cation of serotype-specific sets of reovirus genes sug-
gests that structure/function relationships evolve in as-
sociation with particular virus strains (Virgin et al., 1991).
The correlation between Day 5 spinal cord titer and
reassortant lethality was statistically significant but low.
Thus, these may reflect independent properties of type 3
reovirus neuroinvasiveness. For example, virus spread
from spinal cord to brain may occur soon after infection
of motor neurons and thus is not directly related to
subsequent growth in the spinal cord. Alternatively, for
some reassortants, early replication in the spinal cord
may be dampened by Day 5 and thus would not be
detected in our study, or some reassortants may better
utilize other pathways to infect the brain; for example,
certain gene combinations may facilitate bloodborne
spread. T3D and C9 also differ in their induction of
apoptosis (Tyler, in press), and this mechanism is inde-
pendent of virus growth. Further experiments are needed
to determine the contributions of these mechanisms to
spinal cord infection and lethality.
Virus genes determining neuroinvasion after IM injec-
tion have been identified in the herpes simplex virus.
Two viruses, nonlethal ANG and a lethal mouse brain-
passage derivative, ANGpath, showed similar virulence
after IC injection of adult mice (LD50  1 PFU), yet
differed in neuroinvasiveness (LD50 10
5 vs 108) after
hindlimb injection (Izumi and Stevens, 1990). This differ-
ence correlated with restricted entry into the nervous
system after footpad injection and mapped to the gene
encoding glycoprotein D (gD), an envelope glycoprotein
required for postattachment binding to a coreceptor. Be-
cause replacement of the ANG gD with ANGpath gD did
not fully rescue ANGpath gD  ANG recombinant vi-
ruses to ANGpath LD50 levels, other genes may also be
involved.
Taken together, our results suggest that both inner and
outer capsid proteins influence reovirus neuroinvasive-
ness. In combination with sigma 1 and mu 1 and/or mu
2, inner capsid protein lambda 1 influences virus lethal-
ity, and with lambda 2, influences spinal cord infection
after IM injection. Lambda 1 also can increase the le-
thality of T3D by the natural route of infection.
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MATERIALS AND METHODS
Cells
Spinner-adapted mouse L929 (L) cells (ATCC) were
grown in suspension or monolayer cultures in Joklik’s
modified Eagle’s minimal essential medium (MEM, Irvine
Scientific) supplemented with 5% fetal bovine serum (Hy-
Clone Laboratories) and 2 mM L-glutamine, 1 U penicillin,
and 1 g streptomycin (Irvine Scientific) per milliliter.
Viruses
Reovirus type 3, strain Dearing (T3D), and clone 9 (C9)
were laboratory stocks described previously (Tyler et al.,
1989; Hrdy et al., 1979). T3D  C9 reassortant viruses
were grown from stocks originally isolated by Ken Tyler
and Dinah Bodkin in our laboratory. Viruses were doubly
plaque purified and passaged in L cells to generate
working stocks as described previously (Tyler et al.,
1985). T3D and C9 viruses were purified from infected L
cell lysates by cesium chloride gradient centrifugation
(Furlong et al., 1988).
Animals and inoculations
One-day-old Swiss Webster (Taconic) or NIH Swiss
(National Cancer Institute) mice received intracerebral
inoculations (IC) into the right hemisphere or IM into the
left hindlimb with a Hamilton syringe and 30-gauge nee-
dle. Tissue samples were collected in gelatin-saline
(phosphate-buffered saline, 0.3% gelatin) and stored at
80°C until used for viral titration. To determine virus
lethality, at least three groups of mice (five to six mice per
group) were inoculated by the IC or IM route with serial
dilutions of each virus and monitored daily for signs of
morbidity. Experiments were terminated at 21 days
postinfection, and 50% lethal doses (LD50) were calcu-
lated by the method of Reed and Muench (Reed and
Muench, 1938).
Characterization or reassortants
L cell monolayers were infected with 10 PFU of virus
stock per cell, and cytoplasmic extracts were prepared
for polyacrylamide gel analysis (Tyler et al., 1985). To
resolve certain gene segments, 6 or 10% gels were run
on long (30 cm) gel plates. To identify the parental origin
of closely migrating gene segments, samples were dou-
ble-loaded into wells with T3D or C9 dsRNA.
Determination of viral titer
Tissue samples were frozen and thawed three times
and then sonicated for 30 s using a microtip probe to
homogenize the tissue. L cell monolayers in six-well
plates (106 cells per well) were inoculated in duplicate
with serial 10-fold virus dilutions (Tyler et al., 1985).
Statistical analysis
The effect of the derivation of individual reovirus gene
segments was analyzed by nonparametric (Mann–Whit-
ney) and parametric (t test and multiple regression anal-
ysis) statistical tests (Virgin et al., 1997; Tyler et al., 1996).
Correlation was calculated by Spearmann (nonparamet-
ric) and regression (parametric) analysis. Statistical tests
were performed using Stat-View software (Abacus Con-
cepts, Berkley, CA).
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Note added in proof. Parker et al. (J. Virol. 76: 4483–4496, 2002) and
Broering et al. (J. Virol. 76: 8285–8297; 2002) have recently shown that
the T3D 2 protein contributes to altered factory distribution in T3D
infected cells. This suggests an additional 2 function that could
contribute to virus attenuation.
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